Skip to content

The Mean FPG-to-HbA1c Ratio as a Prognostic Marker for Incident Diabetic Retinopathy: A Retrospective Cohort Study

The Mean FPG-to-HbA1c Ratio as a Prognostic Marker for Incident Diabetic Retinopathy: A Retrospective Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20260520008
Enrollment
180
Registered
2026-05-20
Start date
2025-11-24
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic retinopathy in patients with type 2 diabetes mellitus Diabetic retinopathy

Interventions

This group includes patients diagnosed with type 2 diabetes mellitus who had no evidence of diabetic retinopathy based on ophthalmologic assessment or documented retinal examination during the follow-
Screening,Screening
Participants with type 2 diabetes mellitus who did not develop diabetic retinopathy,Participants with type 2 diabetes mellitus who developed diabetic retinopathy

Sponsors

rajavithi hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Diagnosis of type 2 diabetes mellitus (ICD-10: E11.x or according to ADA criteria) 2. Patients aged 18 years or older at the time of diagnosis 3. Availability of both fasting plasma glucose (FPG) and HbA1c measurements within a comparable time frame (e.g., within 3 months) 4. Documented retinal examination by an ophthalmologist or fundus photograph with an official report 5. Availability of at least 1 year of medical records prior to baseline laboratory measurements 6. At least two hospital visits to ensure continuity of care

Exclusion criteria

Exclusion criteria: 1. Type 1 diabetes mellitus (ICD-10: E10.x) or gestational diabetes 2. Pre-existing retinal diseases unrelated to diabetes (e.g., retinal vein occlusion, age-related macular degeneration, uveitis) 3. Prior history of ocular surgery or laser treatment for DR before the study period 4. Severe systemic conditions that may interfere with glycemic interpretation (e.g., chronic liver failure or advanced chronic kidney disease stage 4 or 5) 5. Missing key data, including FPG, HbA1c, or retinal examination results

Design outcomes

Primary

MeasureTime frame
the development of incident diabetic retinopathy N/A diabetic retinopathy

Secondary

MeasureTime frame
N/A N/A N/A

Countries

Thailand

Contacts

Public Contacthathaichanok rattanapongsate

Rajavithi Hospital

hathaichanok7355@gmail.com0853087355

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026